COMP <GO>
ANDE vs TMO // DIVIDEND YIELD & FCF PAYOUT SAFETY
Andersons Inc. (NASDAQ) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: ANDE 3
— TMO 6
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: ANDE
LAST: $64.29 (+2.91%) • MKT CAP: $2.12B
dividend-safety
1.26%
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
dividend-safety
0.24%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ANDE VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ANDE | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.60% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.70% | 9.30% | -1.60 | TMO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 30.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -2.64% | 2.40% | -5.04 | TMO | /fcf-yield <GO> |
| Operating Margin | — | 17.40% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 6.30% | 15.10% | -8.80 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 9.10% | 3.90% | +5.20 | ANDE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 1.26% | 0.24% | +1.02 | ANDE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 4.50 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 38.6 | 62.9 | -24.30 | TMO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.94 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.6x | 36.3x | -15.70 | ANDE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.12B | $262.22B | -$260.09B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ANDE REV | TMO REV | ANDE GROSS % | TMO GROSS % | ANDE FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.53B | $44.56B | 46.6% | — | -$56.1M | $6.29B |
| FY 2024 | $1.40B | $42.88B | 49.4% | — | $182.3M | $7.27B |
| FY 2023 | $1.63B | $42.86B | — | — | $946.8M | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ANDE // BETA —
TMO // BETA 0.94